<![CDATA[The value of coronary revascularization in Chronic Coronary Syndromes (CCS) depends on whether it delivers the benefit that justifies intervention. Anatomical, physiological, and plaque assessment inform patient selection, but each answers a different clinical question. Applying evolving trial evidence requires attention to the populations studied, outcomes measured, and durability of treatment. Procedural optimization and complete revascularization require the same clinical judgment, with imaging and devices serving defined treatment goals. Medical therapy remains essential regardless of the revascularization strategy. Follow-up connects the procedure to sustained prevention, rehabilitation, and assessment of symptoms and clinical events. Reviewing these outcomes against the original indication, together with the patient’s priorities, provides a practical basis for improving care.]]>
Copyrights © 2026
